Aclarion, Inc. (ACON:NASDAQ) closed at $1.76 on November 3, 2026, down 2.22% on the day. The stock trades 81.2% below its 52-week high of $9.36 and 2.9% above its 52-week low of $1.71. Over the past year, it lost 76.0%. Aclarion, Inc. is part of the Health Care sector.
In 252 trading sessions since November 3, 2025, ACON closed higher on 105 days (42%). Its best day was January 8, 2026 (+42.09%) and its worst was January 9, 2026 (-41.49%). The stock moved 10% or more in a single session 16 times. It opened at least 5% above the previous day's high 3 times.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine.
Find more stocks like ACON with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.